ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,431.60
      -0.04%
      US Tech 100
      19,229.20
      0.32%
      Dow Jones
      38,589.16
      -0.15%
      Brent Oil
      82.525
      0.49%
      Bitcoin
      65,970.35
      -1.00%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Keros Therapeutics Inc (KROS)

      7. Keros Therapeutics Inc (KROS) News

      KROS

      Keros Therapeutics (KROS)

      Keros Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KROS
      DateTimeSourceHeadlineSymbolCompany
      06/04/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      06/04/20248:00AMGlobeNewswire Inc.Keros Therapeutics to Host a Corporate Update Conference Call and WebcastNASDAQ:KROSKeros Therapeutics Inc
      06/03/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
      06/03/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
      06/03/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
      06/03/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      06/03/20248:00AMGlobeNewswire Inc.Keros Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:KROSKeros Therapeutics Inc
      05/30/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      05/28/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      05/28/20244:01PMGlobeNewswire Inc.Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of DirectorsNASDAQ:KROSKeros Therapeutics Inc
      05/14/202410:00AMGlobeNewswire Inc.Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology AssociationNASDAQ:KROSKeros Therapeutics Inc
      05/08/20248:03AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KROSKeros Therapeutics Inc
      05/08/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      05/08/20248:00AMGlobeNewswire Inc.Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial ResultsNASDAQ:KROSKeros Therapeutics Inc
      03/14/20248:00AMGlobeNewswire Inc.Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic SyndromesNASDAQ:KROSKeros Therapeutics Inc
      03/06/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      03/05/20248:02AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      03/05/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      03/05/20248:00AMGlobeNewswire Inc.Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma ConferenceNASDAQ:KROSKeros Therapeutics Inc
      02/28/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      02/28/20244:01PMGlobeNewswire Inc.Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:KROSKeros Therapeutics Inc
      02/23/20245:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
      02/15/20248:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
      02/15/20248:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
      02/15/20248:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
      02/15/20248:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
      01/29/20248:00AMGlobeNewswire Inc.Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual CongressNASDAQ:KROSKeros Therapeutics Inc
      01/09/20248:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KROSKeros Therapeutics Inc
      01/09/20248:00AMGlobeNewswire Inc.Keros Therapeutics Announces Closing of Upsized Public Offering of Common StockNASDAQ:KROSKeros Therapeutics Inc
      01/08/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KROSKeros Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:KROS

      Your Recent History

      NASDAQ
      TAG
      TAGGARES AGRICULTURE CORP.
      Delayed Upgrade Clock